
Neurotech Appoints Peter J. McDonnell, M.D., to the Company’s Board of Directors
CUMBERLAND, R.I., September 03, 2025 — Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, today announced that Peter J. McDonnell, M.D., has been appointed to the Company’s […]